203 related articles for article (PubMed ID: 33526732)
1. RENAL, HEPATIC AND IMMUNE FUNCTION INDICES IN PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY.
Kononets O; Karaiev T; Tkachenko O; Lichman L
Georgian Med News; 2020 Dec; (309):64-71. PubMed ID: 33526732
[TBL] [Abstract][Full Text] [Related]
2. MONITORING OF RENAL, HEPATIC AND IMMUNE FUNCTION INDICES IN PATIENTS WITH NEUROMUSCULAR DISORDERS: AMYOTROPHIC LATERAL SCLEROSIS AND DUCHENNE MUSCULAR DYSTROPHY.
Kononets O; Karaiev T; Lichman L; Kucher O; Kononets O
Georgian Med News; 2022 Jan; (322):131-139. PubMed ID: 35134775
[TBL] [Abstract][Full Text] [Related]
3. A FAMILY HISTORY OF DUCHENNE MUSCULAR DYSTROPHY.
Karaiev T; Tkachenko O; Kononets O; Lichman L
Georgian Med News; 2020 Jun; (303):79-85. PubMed ID: 32841186
[TBL] [Abstract][Full Text] [Related]
4. The frequency of Duchenne muscular dystrophy/Becker muscular dystrophy and Pompe disease in children with isolated transaminase elevation: results from the observational VICTORIA study.
Kansu A; Kuloglu Z; Tümgör G; Taşkın DG; Dalgıç B; Çaltepe G; Demirören K; Doğan G; Tuna Kırsaçlıoğlu C; Arslan D; Işık İA; Demir H; Bekem Ö; Şahin Y; Bayrak NA; Selimoğlu MA; Yavuz S; Taşkaya İE; Altay D;
Front Pediatr; 2023; 11():1272177. PubMed ID: 37818166
[TBL] [Abstract][Full Text] [Related]
5. Renal function in children and adolescents with Duchenne muscular dystrophy.
Braat E; Hoste L; De Waele L; Gheysens O; Vermeersch P; Goffin K; Pottel H; Goemans N; Levtchenko E
Neuromuscul Disord; 2015 May; 25(5):381-7. PubMed ID: 25683700
[TBL] [Abstract][Full Text] [Related]
6. [Enzyme diagnosis in progressive muscular dystrophies, especially in the Duchenne type].
Pernice W; Beckmann R; Renner S; Wais U
Klin Padiatr; 1989; 201(3):167-76. PubMed ID: 2739342
[TBL] [Abstract][Full Text] [Related]
7. Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy.
Zschüntzsch J; Zhang Y; Klinker F; Makosch G; Klinge L; Malzahn D; Brinkmeier H; Liebetanz D; Schmidt J
J Neurochem; 2016 Jan; 136(2):351-62. PubMed ID: 26230042
[TBL] [Abstract][Full Text] [Related]
8. Incidentally Detected Elevated Liver Enzymes: From Liver to Muscle.
Balaji P; Sankaranarayanan S; Venkataraman V; Sankaranarayanan VS
Indian Pediatr; 2017 Apr; 54(4):331-332. PubMed ID: 28474596
[TBL] [Abstract][Full Text] [Related]
9. Transaminitis in Duchenne's muscular dystrophy.
Tay SK; Ong HT; Low PS
Ann Acad Med Singap; 2000 Nov; 29(6):719-22. PubMed ID: 11269976
[TBL] [Abstract][Full Text] [Related]
10. Natural History of Serum Enzyme Levels in Duchenne Muscular Dystrophy and Implications for Clinical Practice.
Rodríguez-Cruz M; Almeida-Becerril T; Atilano-Miguel S; Cárdenas-Conejo A; Bernabe-García M
Am J Phys Med Rehabil; 2020 Dec; 99(12):1121-1128. PubMed ID: 32520799
[TBL] [Abstract][Full Text] [Related]
11. Serum transaminase levels in boys with Duchenne and Becker muscular dystrophy.
McMillan HJ; Gregas M; Darras BT; Kang PB
Pediatrics; 2011 Jan; 127(1):e132-6. PubMed ID: 21149430
[TBL] [Abstract][Full Text] [Related]
12. Safety and disease monitoring biomarkers in Duchenne muscular dystrophy: results from a Phase II trial.
Wagner KR; Guglieri M; Ramaiah SK; Charnas L; Marraffino S; Binks M; Vaidya VS; Palmer J; Goldstein R; Muntoni F
Biomark Med; 2021 Oct; 15(15):1389-1396. PubMed ID: 34533053
[No Abstract] [Full Text] [Related]
13. An examination of some factors influencing creatine kinase in the blood of patients with muscular dystrophy.
Jackson MJ; Round JM; Newham DJ; Edwards RH
Muscle Nerve; 1987 Jan; 10(1):15-21. PubMed ID: 3561434
[TBL] [Abstract][Full Text] [Related]
14. Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism.
Al-Khalidi R; Panicucci C; Cox P; Chira N; Róg J; Young CNJ; McGeehan RE; Ambati K; Ambati J; Zabłocki K; Gazzerro E; Arkle S; Bruno C; Górecki DC
Acta Neuropathol Commun; 2018 Apr; 6(1):27. PubMed ID: 29642926
[TBL] [Abstract][Full Text] [Related]
15. Identifying evidence of cardio-renal syndrome in patients with Duchenne muscular dystrophy using cystatin C.
Villa CR; Kaddourah A; Mathew J; Ryan TD; Wong BL; Goldstein SL; Jefferies JL
Neuromuscul Disord; 2016 Oct; 26(10):637-642. PubMed ID: 27542440
[TBL] [Abstract][Full Text] [Related]
16. Early symptoms of Duchenne muscular dystrophy--description of cases of an 18-month-old and an 8-year-old patient.
Iwańczak F; Stawarski A; Potyrała M; Siedlecka-Dawidko J; Agrawal GS
Med Sci Monit; 2000; 6(3):592-5. PubMed ID: 11208376
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277
[TBL] [Abstract][Full Text] [Related]
18. Vibration therapy tolerated in children with Duchenne muscular dystrophy: a pilot study.
Myers KA; Ramage B; Khan A; Mah JK
Pediatr Neurol; 2014 Jul; 51(1):126-9. PubMed ID: 24830767
[TBL] [Abstract][Full Text] [Related]
19. Serum creatinine level: a supplemental index to distinguish Duchenne muscular dystrophy from Becker muscular dystrophy.
Zhang H; Zhu Y; Sun Y; Liang Y; Li Y; Zhang Y; Deng L; Wen X; Zhang C
Dis Markers; 2015; 2015():141856. PubMed ID: 25852218
[TBL] [Abstract][Full Text] [Related]
20. THE USE OF SERUM CREATINE PHOSPHOKINASE AND OTHER SERUM ENZYMES IN THE DIAGNOSIS OF PROGRESSIVE MUSCULAR DYSTROPHY.
SWAIMAN KF; SANDLER B
J Pediatr; 1963 Dec; 63():1116-9. PubMed ID: 14089817
[No Abstract] [Full Text] [Related]
[Next] [New Search]
